Latest Us Tariffs News

Boss Energy reports a successful ramp-up at its Honeymoon and Alta Mesa uranium projects, achieving first free cash flow and maintaining production and cost guidance for FY2025 amid a complex market backdrop.

Aroa Biosurgery reports a second consecutive quarter of positive operating cash flow and record sales for its Myriad product line, while maintaining full-year FY25 revenue and EBITDA guidance.

Northern Star Resources reported solid March quarter results with strong cash flow and progress on its KCGM Mill Expansion, despite operational setbacks delaying grade uplift and prompting a downward revision of FY25 production guidance.

China’s new export restrictions on molybdenum have shifted global supply dynamics, positioning EV Resources’ Parag copper-molybdenum project in Peru as a strategic alternative supplier to the USA and Americas. With strong drilling results confirming high-grade molybdenum by-product, EV Resources is advancing plans amid growing demand.

Fisher & Paykel Healthcare anticipates increased costs from newly imposed US tariffs on imports from Mexico and China, potentially delaying its gross margin recovery timeline but expects no immediate profit impact for FY2025.

BirdDog Technology reports a strategic pivot with four next-generation product launches, a 20% price increase, and a robust cash position, despite a 13% revenue decline in H1 FY25.

Bathurst Resources reported a first half EBITDA of $27.5 million, surpassing forecasts despite export disruptions, yet lowered its full-year EBITDA guidance to $45-$55 million due to reduced export volumes and softer coal prices.